Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-19-001237

Options or other derivatives

  • Chief Technology Officer acquired 16,722 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Myer Vickesh Chief Technology Officer 2019-01-31 Grant or award · Restricted Stock Units +16,722 16,722 D
Loading xslF345X03/edgar.xml…